These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26886237)
21. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE. Sepulveda VA; Weigel NL; Falzon M Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370 [TBL] [Abstract][Full Text] [Related]
22. Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group. Wadler S; Schwartz EL; Anderson P; Runowicz CD; Chuang L; Del Priore G; Hochster H; Goldberg G; Fields A; Loewen G; Haynes H Cancer J Sci Am; 1999; 5(3):165-70. PubMed ID: 10367173 [TBL] [Abstract][Full Text] [Related]
23. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Blutt SE; Allegretto EA; Pike JW; Weigel NL Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707 [TBL] [Abstract][Full Text] [Related]
24. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
25. 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice. Wu K; Kim HT; Rodriquez JL; Munoz-Medellin D; Mohsin SK; Hilsenbeck SG; Lamph WW; Gottardis MM; Shirley MA; Kuhn JG; Green JE; Brown PH Clin Cancer Res; 2000 Sep; 6(9):3696-704. PubMed ID: 10999763 [TBL] [Abstract][Full Text] [Related]
26. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. Gao M; Ossowski L; Ferrari AC J Cell Physiol; 1999 Jun; 179(3):336-46. PubMed ID: 10228952 [TBL] [Abstract][Full Text] [Related]
27. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991 [TBL] [Abstract][Full Text] [Related]
28. 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. Mernitz H; Smith DE; Zhu AX; Wang XD Cancer Lett; 2006 Nov; 244(1):101-8. PubMed ID: 16413115 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
31. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Kokontis JM; Hay N; Liao S Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399 [TBL] [Abstract][Full Text] [Related]
32. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Nowfar S; Teplitzky SR; Melancon K; Kiefer TL; Cheng Q; Dwived PD; Bischoff ED; Moro K; Anderson MB; Dai J; Lai L; Yuan L; Hill SM Breast Cancer Res Treat; 2002 Mar; 72(1):33-43. PubMed ID: 12004806 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
34. p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Polek TC; Stewart LV; Ryu EJ; Cohen MB; Allegretto EA; Weigel NL Endocrinology; 2003 Jan; 144(1):50-60. PubMed ID: 12488329 [TBL] [Abstract][Full Text] [Related]
35. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells. Tatebe H; Shimizu M; Shirakami Y; Tsurumi H; Moriwaki H Clin Cancer Res; 2008 May; 14(9):2806-12. PubMed ID: 18451248 [TBL] [Abstract][Full Text] [Related]
36. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent. Zhao XY; Ly LH; Peehl DM; Feldman D Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780 [TBL] [Abstract][Full Text] [Related]
37. The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone. Jennbacken K; Gustavsson H; Tesan T; Horn M; Vallbo C; Welén K; Damber JE Prostate; 2009 Aug; 69(11):1164-75. PubMed ID: 19399749 [TBL] [Abstract][Full Text] [Related]
38. 9-cis retinoic acid regulation of rat growth hormone gene expression: potential roles of multiple nuclear hormone receptors. Sugawara A; Yen PM; Chin WW Endocrinology; 1994 Nov; 135(5):1956-62. PubMed ID: 7956917 [TBL] [Abstract][Full Text] [Related]
39. The induction of prostaglandin E synthase and upregulation of cyclooxygenase-2 by 9-cis retinoic acid. Tsukamoto H; Hishinuma T; Tayama R; Narahara K; Suzuki N; Tomioka Y; Goto J Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):61-74. PubMed ID: 15560116 [TBL] [Abstract][Full Text] [Related]